Related Experiment Videos
Aseptic meningitis secondary to metrizamide lumbar myelography in a 4 1/2-month-old infant
Pediatrics
|August 1, 1985
Abstract:
Although metrizamide has been used as a contrast agent for myelography for the past decade, there are few reports of its use in the pediatric population. Aseptic meningitis has rarely been reported as an adverse effect of metrizamide in adults. The first pediatric case of aseptic meningitis following lumbar myelography with metrizamide is reported.
Insights
Metrizamide myelography is uncommon in children. This report details the first pediatric case of aseptic meningitis, a rare adverse effect, following this procedure.
Area of Science:
- Neurology
- Radiology
- Pediatrics
Background:
- Metrizamide is a widely used contrast agent for myelography.
- Its use in pediatric populations is not well-documented.
- Aseptic meningitis is a rare adverse effect in adults.
Observation:
- A pediatric patient underwent lumbar myelography using metrizamide.
- The patient subsequently developed symptoms consistent with aseptic meningitis.
Findings:
- This represents the first reported pediatric case of aseptic meningitis after metrizamide myelography.
- The findings highlight a potential adverse event in pediatric patients.
Implications:
- Clinicians should be aware of the potential risk of aseptic meningitis in pediatric patients undergoing metrizamide myelography.
- Further research into the safety profile of metrizamide in children is warranted.